<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Reperfusion <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> are currently attributed to ionic imbalance and <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="3" ids="41774">Tamoxifen</z:chebi> is a potent <z:chebi fb="11" ids="22586">antioxidant</z:chebi> that also modulates some ionic transport pathways </plain></SENT>
<SENT sid="2" pm="."><plain>In this work we tried to correlate the electrophysiologic effects of 1, 2 and 5 µM <z:chebi fb="3" ids="41774">tamoxifen</z:chebi> with the incidence and severity of <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> appearing on reperfusion after 10 min of <z:e sem="disease" ids="C0151814" disease_type="Disease or Syndrome" abbrv="">coronary occlusion</z:e> in isolated hearts from female rats </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> <z:chebi fb="3" ids="41774">tamoxifen</z:chebi> concentrations inhibited the action potential shortening observed in the control hearts during late <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (6 to 10 min), whereas 2 and 5 µM also reduced the resting membrane potential depolarization </plain></SENT>
<SENT sid="4" pm="."><plain>The incidence of sustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> and/or <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> on reperfusion decreased from 10/12 (control group) to 5/10 (1 µM, P=0.1718), 4/12 (2 µM, P=0.0361) and 2/10 (5 µM, P=0.0083) </plain></SENT>
<SENT sid="5" pm="."><plain>The possible role of <z:chebi fb="76" ids="17996">chloride</z:chebi> currents activated by cell swelling in these effects was explored in hearts submitted to a 10 min hypotonic challenge, where <z:chebi fb="3" ids="41774">tamoxifen</z:chebi> (5 µM) blocked the action potential shortening and the late resting membrane potential depolarization produced by <z:mp ids='MP_0004144'>hypotonicity</z:mp>, mimicking its action in late <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="3" ids="41774">Tamoxifen</z:chebi> produced a similar increase of the total <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity of myocardial samples at <z:hpo ids='HP_0000001'>all</z:hpo> the concentration tested </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, our data strongly suggest that the antiarrhythmic action of this agent is mediated by its electrophysilogical effect derived from modulation of <z:chebi fb="76" ids="17996">chloride</z:chebi> currents activated by cell swelling </plain></SENT>
</text></document>